Nuvaira
Maple Grove, Minnesota, United States · Healthcare, medical devices · 66 employees
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headq
Funding history
- Funding Round — $35.8M — Mar 2026
- Series seed — $979K — Aug 2025
- Series pre-seed — $53K — May 2024
- Funding Round — $31.3M — Jan 2022
- Funding Round — $17.4M — Jul 2020
Recent signals
- Mar 04, 2026: Raised $35.8M
- Aug 25, 2025: Raised $979K in Series seed
- May 09, 2024: Raised $53K in Series pre-seed
- Jan 19, 2022: Raised $31.3M
- Jul 29, 2020: Raised $17.4M
- May 15, 2018: Raised $31.3M
See plans & pricing → Track Nuvaira’s funding, hiring, and signals — with verified contacts — on Fundz.